56550 Federal Register / Vol. 75, No. 179 / Thursday, September 16, 2010 / Notices 

Time and Date: 9 a.m.–5:30 p.m., 

September 15–16, 2010. 

Place: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland. 

Status: Open to the public. 

Purpose: The ICD–9–CM Coordination 

and Maintenance (C&M) Committee will 

hold the last meeting of the 2010 

calendar year cycle on Wednesday and 

Thursday September 15–16, 2010. The 

C&M meeting is a public forum for the 

presentation of proposed modifications 

to the International Classification of 

Diseases, Ninth-Revision, Clinical 

Modification. There will be telephone 

lines available from 9 a.m. until 12:30 

p.m. and 2:15 p.m. until 5:30 p.m. 

(Wednesday) and 9 until 12:30 and 1:30 

until 3:15 p.m. (Thursday) for those who 

are unable to attend the meeting in 

person. The toll-free dial-in number for 

external participants is 1–800–837– 

1935; participant codes for the 

respective sessions are: 888801009, 

88803327, 88805029, and 88808234. 

Participants attending by telephone do 

not need to formally register for the 

meeting. Dial-in lines are available on a 

first come, first served basis. 

Matters To Be Discussed: Tentative 

agenda items include: 

September 15, 2010 

ICD–10 Topics (9–12:30) 

Freeze update 

General Equivalence Maps (GEMs)* 

MS–DRG Impact Analysis 

V28.0 ICD–10 MS–DRGs 

ICD–10–CM/ICD–10–PCS updates 

* Section 10109(c) of the Patient Protection 

and Affordable Care Act and the 

Reconciliation Act of 2010 (PPACA) requires 

the Secretary of Health and Human Services 

(HHS) to task the C&M Committee to convene 

a meeting before January 1, 2011, to receive 

stakeholder input regarding the crosswalk 

between the Ninth and Tenth Revisions of 

the International Classification of Diseases 

(ICD–9, and ICD–10, respectively), posted to 

the CMS Web site at http://www.cms.gov/ 

ICD10, for the purpose of making appropriate 

revisions to said crosswalk. 

Section 10109(c) further states that any 

revised crosswalk be treated as a code set for 

which a standard has been adopted by the 

Secretary, and that revisions to this 

crosswalk be posted to the CMS Web site. 

The C&M Committee will use the first half 

of the first day of the September C&M 

Committee meeting, 9 a.m. to 12:30 p.m. 

Wednesday, September 15, 2010, to fulfill the 

above-referenced PPACA requirements for 

this meeting to be held prior to January 1, 

2011, and receive public input regarding the 

above-referenced crosswalk revision. 

No other meeting will be convened by the 

C&M Committee for this purpose. Interested 

parties and stakeholders should be prepared 

to submit their written comments and other 

relevant documentation at the meeting, or no 

later than November 12, 2010 to the 

following addresses: 

ICD–9–CM procedure topics: 

Contrast Dye Removal 

Endovascular partial occlusion of 

abdominal aorta 

Endovascular Intracranial Aneurysm 

Embolization 

Fenestrated AAA Endovascular Graft 

Implantation of an Anti-Microbial 

Envelope 

Pulmonary Artery Pressure Monitoring 

Addenda (procedures) 

September 16, 2010 

Corticobasal degeneration 

Complication of stem cell transplant 

Gastroparesis 

Glaucoma 

Hepatopulmonary syndrome 

Interstitial lung diseases 

Malnutrition 

Mesh erosion 

Pseudobulbar affect 

Transfusion transmitted infections 

Genitourinary conditions 

Addenda (diagnoses) 

Contact Person for Additional 

Information: Donna Pickett, Medical 

Systems Administrator, Classifications 

and Public Health Data Standards Staff, 

NCHS, 3311 Toledo Road, Room 2337, 

Hyattsville, Maryland 20782, e-mail 

dfp4@cdc.gov, telephone 301–458–4434 

(diagnosis), Mady Hue, Health 

Insurance Specialist, Division of Acute 

Care, CMS, 7500 Security Blvd., 

Baltimore, Maryland 21244, e-mail 

marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

Note: CMS and NCHS will no longer be 

providing paper copies of handouts for the 

meeting. Electronic copies of all meeting 

materials will be posted on the CMS and 

NCHS Web sites prior to the meeting at 

http://www.cms.hhs.gov/ICD9Provider

DiagnosticCodes/03_

meetings.asp#TopOfPage and http:// 

www.cdc.gov/nchs/icd/icd9cm_

maintenance.htm. 

Notice: Because of increased security 

requirements CMS has instituted 

stringent procedures for entrance into 

the building by non-government 

employees. Persons without a 

government I.D. will need to show an 

official form of picture I.D. (such as a 

drivers license), and sign-in at the 

security desk upon entering the 

building. 

Those who wish to attend a specific 

ICD–9–CM C&M meeting in the CMS 

auditorium must submit their name and 

organization in addition to the meeting 

visitor list. Those wishing to attend the 

September 15–16, 2010 meeting must 

submit their name and organization by 

September 10, 2010 for inclusion on the 

visitor list. This visitor list will be 

maintained at the front desk of the CMS 

building and used by the guards to 

admit visitors to the meeting. Those 

who attended previous ICD–9–CM C&M 

meetings will no longer be 

automatically added to the visitor list. 

You must request inclusion of your 

name prior to each meeting you attend. 

Register to attend the meeting on-line 

at: http://www.cms.hhs.gov/apps/ 

events/. 

For questions about the registration 

process please contact Mady Hue (410– 

786–4510 or Marilu.hue@cms.hhs.gov). 

Notice: This is a public meeting. However, 

because of fire code requirements, should the 

number of attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: September 8, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–23092 Filed 9–15–10; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the National 

Advisory Neurological Disorders and 

Stroke Council. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted they 

the National Institute of Neurological 

Disorders and Stroke, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of 

Neurological Disorders and Stroke. 

Date: October 24–25, 2010. 

Time: 7 p.m. to 6:30 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 179 / Thursday, September 16, 2010 / Notices 56551 

Avenue, Chesapeake Room, Bethesda, MD 

20814. 

Contact Person: Alan P. Koretsky, PhD, 

Scientific Director, Division of Intramural 

Research, National Institute of Neurological 

Disorders and Stroke, National Institutes of 

Health, 35 Convent Drive, Room 6A 908, 

Bethesda, MD 20892, (301) 435–2232, 

koretskya@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS). 

Dated: September 9, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23156 Filed 9–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Population Sciences 

Subcommittee. 

Date: November 8–9, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Carla T. Walls, PhD, 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5B01, Bethesda, MD 20892, 

301–435–6898, wallsc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 10, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23155 Filed 9–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, NIA. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute on Aging, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, NIA. 

Date: October 26, 2010. 

Closed: 8 a.m. to 8:30 a.m. 

Agenda: To review and evaluate opening 

remarks; Board business; Review and 

evaluate personal qualifications and 

performance, and competence of individual 

investigators. 

Place: National Institute on Aging, 

Biomedical Research Center, 251 Bayview 

Boulevard, 3rd Floor Conference Room, 

Baltimore, MD 21224. 

Open: 8:30 a.m. to 12 p.m. 

Agenda: Committee discussion, individual 

presentations, laboratory overview. 

Place: National Institute on Aging, 

Biomedical Research Center, 251 Bayview 

Boulevard, 3rd Floor Conference Room, 

Baltimore, MD 21224. 

Closed: 12 p.m. to 12:15 p.m. 

Agenda: To review and evaluate senior 

laboratory investigators meet individually 

and privately with BSC members. 

Place: National Institute on Aging, 

Biomedical Research Center, 251 Bayview 

Boulevard, 3rd Floor Conference Room, 

Baltimore, MD 21224. 

Closed: 12:15 p.m. to 3 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institute on Aging, 

Biomedical Research Center, 251 Bayview 

Boulevard, 3rd Floor Conference Room, 

Baltimore, MD 21224. 

Contact Person: Michele K. Evans, MD, 

Acting Scientific Director, National Institute 

on Aging, 251 Bayview Boulevard, Suite 100, 

Room 04C221, Baltimore, MD 21224, 410– 

558–8110, ME42V@NIH.GOV. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 10, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–23154 Filed 9–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK DEM 

Fellowships. 

Date: October 13–14, 2010. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Radisson National Airport, 2020 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Michael W. Edwards, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 750, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8886, 

edwardsm@extra.niddk.nih.gov. 

mstockstill on DSKH9S0YB1PROD with NOTICES